Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

CEO Ron Kruszewski and Yahoo Finance Executive Editor Brian Sozzi at the 2025 World Economic Forum in Davos, Switzerland, to talk about the macro issues impacting the investment banking firm, ...

Stifel raised the firm’s price target on Werner (WERN) to $35 from $30 and keeps a Hold rating on the shares. 2024 largely proved to be “the ...

Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while 2024 ...

Stifel raised the firm’s price target on Old Dominion (ODFL) to $193 from $176 and keeps a Hold rating on the shares. 2024 largely proved to be ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

Fintel reports that on January 22, 2025, Stifel initiated coverage of Cytokinetics (NasdaqGS:CYTK) with a Buy recommendation.

On Wednesday, Vince Holding Corp (VNCE) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.60 or -20.34% from the prior close of $2.95. The stock opened at $2.95 and ...

Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.